Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: BRISTOL-MYERS SQUIBB COMPANY
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2025-02-24 to 2025-03-02
Current total value of award: $335042.65
Description: ANTINEOPLASTIC/ BCMA DIRECTED CAR-T CELL IMMUNOTHERAPY. QTY: 1, BREYANZI, 50-110M CAR POS T-CELL CTN US. LISOCABTAGENE MARALEUCEL APPROVED FOR A VETERAN PATIENT.